DC Field | Value | Language |
dc.contributor.author | Gubareva, V. O. | - |
dc.contributor.author | Pazhinsky, A. L. | - |
dc.contributor.author | Lugovskoy, S. S. | - |
dc.contributor.author | Dubovtsova, E. Y. | - |
dc.contributor.author | Vain, D. S. | - |
dc.date.accessioned | 2022-04-24T10:40:10Z | - |
dc.date.available | 2022-04-24T10:40:10Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Pharmacological correction of morphofunctional retinal injury using 11-amino acid fragment of darbepoetin in the experiment / V.O. Gubareva [et al.] // Research Results in Pharmacology. - 2019. - Vol. 5, № 3.- P. 43-55. - Doi: 10.3897/rrpharmacology.5.38730. - Refer.: p. 54-55. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46313 | - |
dc.description.abstract | The retinoprotective effect of the 11-amino acid fragment of darbepoetin PRK-002 on the models of hypertensive retinal angiopathy and hypertensive neuroretinopathy in Wistar rats was investigated in comparison with carbamylated darbepoetin and sulodexide. The study revealed angio- and neuroprotective activity of the 11-amino acid fragment of darbepoetin PRK-002 in correction of retinal injury formed on the background of hypertension | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | 11-amino acid fragment of darbepoetin | ru |
dc.subject | hypertensive neuroretinopathy | ru |
dc.subject | PRK-002 | ru |
dc.subject | retinal angiopathy | ru |
dc.subject | Wistar rats | ru |
dc.title | Pharmacological correction of morphofunctional retinal injury using 11-amino acid fragment of darbepoetin in the experiment | ru |
dc.type | Article | ru |
Appears in Collections: | Vol. 5, № 3
|